Endoscopy 2006; 38: 40-47
DOI: 10.1055/s-2006-946650
Invited papers
Pancreato-biliary tumors
© Georg Thieme Verlag KG Stuttgart · New York

Cystic pancreatic lesions: Can we diagnose them accurately what to look for? FNA marker molecular analysis resection, surveillance, or endoscopic treatment?

W. R. Brugge1
  • 1GI Unit, Blake 452, Massachusetts General Hospital, Boston
Further Information

Publication History

Publication Date:
26 June 2006 (online)

Introduction

Cystic lesions of the pancreas consist of a spectrum of benign, pre-malignant, and malignant malignancies. In the past, cystic neoplasms of the pancreas were thought to be relatively rare, but the widespread use of cross sectional imaging has dramatically increased ability to detect these lesions. Although the vast majority of pancreatic cysts are discovered incidentally, large or invasive lesions may produce sufficient symptoms to cause the patient to seek medical attention.

Cystic neoplasms are often confused or misdiagnosed as pseudocysts or peripancreatic collections of inflammatory fluid that may morphologically mimic cystic neoplasms. Furthermore, the presenting symptoms of pseudocysts may be identical to the symptoms associated with cystic neoplasms.

Cystic neoplasms of the pancreas are traditionally organized by the type of lining epithelium since this feature dominates the risk of malignancy and management [1] (Table [1]). There are three types of mucinous lesions, benign mucinous cystadenomas, malignant mucinous cystic lesions, and intra-ductal papillary mucinous neoplasms (IPMNs). The non-mucinous lesions include serous cystadenomas, cystic endocrine tumors and other rare lesions.

Table 1 Tumor Type Gender Age Morphology Type of Epithelium Risk of Malignancy Mucinous Cystadenoma Female Middle-Aged Unilocular Mucinous Moderate Mucinous Cystic Neoplasm Female Middle-Aged Associated mass Malignant Mucinous High Intra-ductal Papillary Mucinous Tumor Mixed Elderly Unilocular, septated, associated dilated ducts Papillary Mucinous Moderate Serous Cystadenoma Female Middle-Aged Microcystic Serous (PAS positive for glycogen) Low Cystic Endocrine Tumor Mixed Middle-Aged Associated mass Endocrine Low Solid Cystic Pseudopapillary Tumor Female Young Mixed solid and cystic Endocrine-like Low

References

  • 1 Brugge W R, Lauwers G Y, Sahani D. et al . Cystic neoplasms of the pancreas.  N Engl J Med. 2004;  351 1218-1226
  • 2 Kimura W, Nagai H, Kuroda A. et al . Analysis of small cystic lesions of the pancreas.  Int J Pancreatol. 1995;  18 197-206
  • 3 Zhang X M, Mitchell D G, Dohke M. et al . Pancreatic cysts: depiction on single-shot fast spin-echo MR images.  Radiology. 2002;  223 547-553
  • 4 Ikeda M, Sato T, Morozumi A. et al . Morphologic changes in the pancreas detected by screening ultrasonography in a mass survey, with special reference to main duct dilatation, cyst formation, and calcification.  Pancreas. 1994;  9 508-512
  • 5 Compton C C. Serous cystic tumors of the pancreas.  Semin Diagn Pathol. 2000;  17 43-55
  • 6 Bassi C, Salvia R, Molinari E. et al . Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symptoms and see at imaging or vice versa?.  World J Surg. 2003;  27 319-323
  • 7 Hammel P. [Diagnostic value of cyst fluid analysis in cystic lesions of the pancreas: current data, limitations, and perspectives].  J Radiol. 2000;  81 487-490
  • 8 Moore P S, Zamboni G, Brighenti A. et al . Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q.  Am J Pathol. 2001;  158 317-321
  • 9 Vortmeyer A O, Lubensky I A, Fogt F. et al . Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.  Am J Pathol. 1997;  151 951-956
  • 10 Ahmad N A, Kochman M L, Brensinger C. et al . Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions.  Gastrointest Endosc. 2003;  58 59-64
  • 11 Khalid A, McGrath K M, Zahid M. et al . The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology.  Clin Gastroenterol Hepatol. 2005;  3 967-973
  • 12 Yoshizawa K, Nagai H, Sakurai S. et al . Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.  Virchows Arch. 2002;  441 437-443
  • 13 Khurana B, Mortele K J, Glickman J. et al . Macrocystic serous adenoma of the pancreas: radiologic-pathologic correlation.  AJR Am J Roentgenol. 2003;  181 119-123
  • 14 Tanaka M. Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment.  Pancreas. 2004;  28 282-288
  • 15 Furuta K, Watanabe H, Ikeda S. Differences between solid and duct-ectatic types of pancreatic ductal carcinomas.  Cancer. 1992;  69 1327-1333
  • 16 Kann P, Bittinger F, Engelbach M. et al . Endosonography of insulin-secreting and clinically non-functioning neuroendocrine tumors of the pancreas: criteria for benignancy and malignancy.  Eur J Med Res. 2001;  6 385-390
  • 17 Marcos H B, Libutti S K, Alexander H R. et al . Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.  Radiology. 2002;  225 751-758
  • 18 Notohara K, Hamazaki S, Tsukayama C. et al . Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.  Am J Surg Pathol. 2000;  24 1361-1371
  • 19 Wiesenauer C A, Schmidt C M, Cummings O W. et al . Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.  Arch Surg. 2003;  138 610-7; discussion 617 - 618
  • 20 Holly E A, Chaliha I, Bracci P M. et al . Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area.  Clin Gastroenterol Hepatol. 2004;  2 510-517
  • 21 Sand J, Nordback I. The differentiation between pancreatic neoplastic cysts and pancreatic pseudocyst.  Scand J Surg. 2005;  94 161-164
  • 22 Caillot J L, Rongieras F, Voiglio E. et al . A new case of congenital cyst of the pancreas.  Hepatogastroenterology. 2000;  47 916-918
  • 23 Curry C A, Eng J, Horton K M. et al . CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment?.  AJR Am J Roentgenol. 2000;  175 99-103
  • 24 Fukukura Y, Fujiyoshi F, Hamada H. et al . Intraductal papillary mucinous tumors of the pancreas. Comparison of helical CT and MR imaging.  Acta Radiol. 2003;  44 464-471
  • 25 Kubota K, Noie T, Sano K. et al . Impact of intraoperative ultrasonography on surgery for cystic lesions of the pancreas.  World J Surg. 1997;  21 72-76; discussion 77
  • 26 Sperti C, Pasquali C, Decet G. et al . F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.  J Gastrointest Surg. 2005;  9 22-28; discussion 28 - 29
  • 27 Torresan F, Casadei R, Solmi L. et al . The role of ultrasound in the differential diagnosis of serous and mucinous cystic tumours of the pancreas.  Eur J Gastroenterol Hepatol. 1997;  9 169-172
  • 28 Chatelain D, Hammel P, O'Toole D. et al . Macrocystic form of serous pancreatic cystadenoma.  Am J Gastroenterol. 2002;  97 2566-2571
  • 29 Cheng T Y, Su C H, Shyr Y M. et al . Management of pancreatic lesions in von Hippel-Lindau disease.  World J Surg. 1997;  21 307-312
  • 30 Sahani D, Prasad S, Saini S. et al . Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography.  Gastrointest Endosc Clin N Am. 2002;  12 657-672
  • 31 Sugiyama M, Atomi Y, Hachiya J. Intraductal papillary tumors of the pancreas: evaluation with magnetic resonance cholangiopancreatography.  Am J Gastroenterol. 1998;  93 156-159
  • 32 Madura J A, Wiebke E A, Howard T J. et al . Mucin-hypersecreting intraductal neoplasms of the pancreas: a precursor to cystic pancreatic malignancies.  Surgery. 1997;  122 786-92; discussion 792 - 793
  • 33 Azar C, Van de Stadt J, Rickaert F. et al . Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients.  Gut. 1996;  39 457-464
  • 34 Brugge W R. Evaluation of pancreatic cystic lesions with EUS.  Gastrointest Endosc. 2004;  59 698-707
  • 35 Ahmad N A, Kochman M L, Lewis J D. et al . Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas?.  Am J Gastroenterol. 2001;  96 3295-3300
  • 36 Brandwein S L, Farrell J J, Centeno B A. et al . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS.  Gastrointest Endosc. 2001;  53 722-727
  • 37 Terris B, Ponsot P, Paye F. et al . Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct.  Am J Surg Pathol. 2000;  24 1372-1377
  • 38 Lee L S, Saltzman J R, Bounds B . et al . EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors.  Clin Gastroenterol Hepatol. 2005;  3 231-236
  • 39 Volmar K E, Vollmer R T, Jowell P S. et al . Pancreatic FNA in 1000 cases: a comparison of imaging modalities.  Gastrointest Endosc. 2005;  61 854-861
  • 40 O'Toole D, Palazzo L, Hammel P. et al . Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.  Gastrointest Endosc. 2004;  59 823-829
  • 41 Centeno B A, Warshaw A L, Mayo-Smith W. et al . Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates.  Acta Cytol. 1997;  41 972-980
  • 42 Recine M, Kaw M, Evans D B. et al . Fine-needle aspiration cytology of mucinous tumors of the pancreas.  Cancer. 2004;  102 92-99
  • 43 Sperti C, Pasquali C, Guolo P. et al . Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.  Cancer. 1996;  78 237-243
  • 44 Yamaguchi K, Enjoji M. Cystic neoplasms of the pancreas.  Gastroenterology. 1987;  92 1934-1943
  • 45 Walsh R M, Henderson J M, Vogt D P. et al . Prospective preoperative determination of mucinous pancreatic cystic neoplasms.  Surgery. 2002;  132 628-33; discussion 633 - 634
  • 46 Frossard J L, Amouyal P, Amouyal G. et al . Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions.  Am J Gastroenterol. 2003;  98 1516-1524
  • 47 Brugge W R, Lewandrowski K, Lee-Lewandrowski E. et al . Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.  Gastroenterology. 2004;  126 1330-1336
  • 48 Hammel P, Voitot H, Vilgrain V. et al . Diagnostic value of CA 72 - 4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions.  Eur J Gastroenterol Hepatol. 1998;  10 345-348
  • 49 van der Waaij L A, van Dullemen H M, Porte R J. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.  Gastrointest Endosc. 2005;  62 383-389
  • 50 Zhou G X, Huang J F, Li Z S. et al . Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.  World J Gastroenterol. 2004;  10 1337-1340
  • 51 Telford J J, Carr-Locke D L. The role of ERCP and pancreatoscopy in cystic and intraductal tumors.  Gastrointest Endosc Clin N Am. 2002;  12 747-757
  • 52 Dachman A H, Namieno T, Ichimura T. et al . Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography.  Radiology. 1998;  208 231-237
  • 53 Koito K, Namieno T, Ichimura T. et al . Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography.  Radiology. 1998;  208 231-237
  • 54 Sugiyama M, Atomi Y, Saito M. Intraductal papillary tumors of the pancreas: evaluation with endoscopic ultrasonography.  Gastrointest Endosc. 1998;  48 164-171
  • 55 Kobayashi G, Fujita N, Noda Y. et al . Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.  J Gastroenterol. 2005;  40 744-751
  • 56 Irie H, Yoshimitsu K, Aibe H. et al . Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography.  J Comput Assist Tomogr. 2004;  28 117-122
  • 57 Gan S I, Thompson C C, Lauwers G Y. et al . Ethanol lavage of pancreatic cystic lesions: initial pilot study.  Gastrointest Endosc. 2005;  61 746-752
  • 58 Kimura W, Makuuchi M. Operative indications for cystic lesions of the pancreas with malignant potential - our experience.  Hepatogastroenterology. 1999;  46 483-491
  • 59 Fernandez del Castillo C F, Targarona J, Thayer S P. et al . Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.  Arch Surg. 2003;  138 427-434
  • 60 Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association.  Ann Surg. 1999;  230 152-161
  • 61 Gigot J F, Deprez P, Sempoux C. et al . Surgical management of intraductal papillary mucinous tumors of the pancreas: the role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis.  Arch Surg. 2001;  136 1256-1262
  • 62 Chari S T, Yadav D, Smyrk T C. et al . Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.  Gastroenterology. 2002;  123 1500-1507
  • 63 Spinelli K S, Fromwiller T E, Daniel R A. et al . Cystic pancreatic neoplasms: observe or operate.  Ann Surg. 2004;  239 651-7; discussion 657 - 659
  • 64 Sohn T A, Yeo C J, Cameron J L. et al . Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.  Ann Surg. 2004;  239 788-97; discussion 797 - 799
  • 65 Lai E C, Lau W Y. Intraductal papillary mucinous neoplasms of the pancreas.  Surgeon. 2005;  3 317-324
  • 66 Falconi M, Salvia R, Bassi C. et al . Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas.  Br J Surg. 2001;  88 376-381
  • 67 Suzuki Y, Atomi Y, Sugiyama M. et al . Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor.  Pancreas. 2004;  28 241-246
  • 68 Kobari M, Egawa S, Shibuya K. et al . Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management.  Arch Surg. 1999;  134 1131-1136

William R. Brugge, M.D.

GI Unit

Blake 452

Massachusetts General Hospital

Boston, MA 02114

Phone: 001-617-724-3715

Fax: 001-617-724-5996

Email: brugge.william@mgh.harvard.edu

    >